Business Segments · Capital Expenditures During Period
MedSurg and Neurotechnology — Capital Expenditures During Period
Stryker MedSurg and Neurotechnology — Capital Expenditures During Period increased by 23.4% to $58.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.4%, from $53.00M to $58.00M. Over 3 years (FY 2021 to FY 2024), MedSurg and Neurotechnology — Capital Expenditures During Period shows an upward trend with a 11.9% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ3 2025
How to read this metric
Higher capital expenditures indicate investment in future growth and capacity, while lower levels may suggest a focus on cash preservation or a mature asset base.
Detailed definition
Measures the cash spent by the MedSurg and Neurotechnology segment to acquire, upgrade, or maintain physical assets such...
Peer comparison
Standard metric for assessing capital intensity and growth investment across the medical device sector.
Metric ID:
syk_segment_medsurg_and_neurotechnology_capital_expenditures_during_periodHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $49.25M | $49.25M | $49.25M | $43.25M | $43.25M | $43.25M | $43.25M | $44.75M | $44.75M | $44.75M | $44.75M | $41.00M | $42.00M | $53.00M | $140.00M | $48.00M | $47.00M | $58.00M |
| QoQ Change | — | +0.0% | +0.0% | -12.2% | +0.0% | +0.0% | +0.0% | +3.5% | +0.0% | +0.0% | +0.0% | -8.4% | +2.4% | +26.2% | +164.2% | -65.7% | -2.1% | +23.4% |
| YoY Change | — | — | — | — | -12.2% | -12.2% | -12.2% | +3.5% | +3.5% | +3.5% | +3.5% | -8.4% | -6.1% | +18.4% | +212.8% | +17.1% | +11.9% | +9.4% |
Range$41.00M – $140.00M
CAGR+3.9%
Avg YoY Growth+16.6%
Median YoY Growth+3.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's medsurg and neurotechnology — capital expenditures during period?
- Stryker (SYK) reported medsurg and neurotechnology — capital expenditures during period of $58.00M in Q3 2025.
- How has Stryker's medsurg and neurotechnology — capital expenditures during period changed year-over-year?
- Stryker's medsurg and neurotechnology — capital expenditures during period increased by 9.4% year-over-year, from $53.00M to $58.00M.
- What is the long-term trend for Stryker's medsurg and neurotechnology — capital expenditures during period?
- Over 3 years (2021 to 2024), Stryker's medsurg and neurotechnology — capital expenditures during period has grown at a 11.9% compound annual growth rate (CAGR), from $197.00M to $276.00M.
- What does medsurg and neurotechnology — capital expenditures during period mean?
- The amount of money invested in physical assets and infrastructure for this segment during the period.